Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
IR-MED Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
IRME
Over the counter
3841
https://www.ir-medical.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for IR-MED Inc
IRME: IR-Med’s Potential for Profitable Growth in Coming Years Supports Price Target of $3.00.
- Apr 11th, 2024 1:46 pm
IR-MED’s PressureSafe™ Receives FDA Listing for the Indication of Decision Support Device for Pressure Injuries
- Apr 5th, 2024 1:00 pm
IRME: IR-Med’s positive safety and efficacy data from recent PressureSafe study supports price target of $3.00.
- Feb 21st, 2024 1:23 pm
IR-MED Reports 92% Efficacy for PressureSafe™ in Early, Non-Invasive, Skin Color Agnostic Detection of Pressure Injuries
- Feb 20th, 2024 2:15 pm
IR-MED to Report New Clinical Efficacy Data for Detection of Pressure Injuries with its AI- Based PressureSafe™ Device at NPIAP 2024 Annual Conference on February 16
- Feb 13th, 2024 2:15 pm
IR-MED Awarded Most Innovative Non-Invasive Diagnostics Technology Developer 2023 by Corporate Vision Magazine
- Dec 21st, 2023 2:15 pm
IR-MED Granted Patent in Israel for its AI-Driven Platform Technology: Non-Invasive Analysis of Subcutaneous Tissue
- Dec 7th, 2023 2:15 pm
IRME: IR-MED reports 3rd quarter financial results which were in line with expectations.
- Nov 22nd, 2023 9:53 am
IR-MED Appoints Healthcare Executive and Entrepreneur Tzur Di-Cori as Chief Executive Officer
- Oct 4th, 2023 8:05 pm
IR-MED to Conduct Usability Study with Methodist Healthcare of San Antonio for its PressureSafe Device Which is Slated for U.S. Launch in H1 2024
- Sep 26th, 2023 1:00 pm
IR-MED Appoints Richard Serbin, Esq. to its Advisory Board
- Sep 13th, 2023 1:15 pm
IRME: Initiating coverage of IR-Med, Inc., a development stage medical device company that is creating a technology platform for non-invasive devices to be used as a decision support system tool (DSS).
- Aug 28th, 2023 1:40 pm
IR-MED Chairman & Interim CEO Issues Letter to Shareholders
- Aug 21st, 2023 1:15 pm
IR-MED’s AI-Powered Infra-Red Spectrographic Decision Support System PressureSafe Device Demonstrates High Efficacy in Detecting Pressure Injuries with 96% Accuracy: Potential to Set a New Standard of Care
- Jul 17th, 2023 1:15 pm
IR-MED Honors Juneteenth with Commitment to Healthcare Equality: PressureSafe Device Sees Beneath the Skin to Address Inequality in Pressure Injuries
- Jun 12th, 2023 1:15 pm
IR-Med Appoints Dr. Lynn Eschenbacher to its Advisory Board as Company Advances Toward Launch of its PressureSafe Wound Care Device
- Jun 7th, 2023 1:28 pm
IR-Med’s PressureSafe Noninvasive Wound Care Device to be Demonstrated at Northwell Health’s 10th Annual Shining the Light on Wound Care Symposium
- May 19th, 2023 1:15 pm
Scroll